Vernal Biosciences

About Vernal Biosciences

Vernal Biosciences is a leading mRNA CDMO (Contract Development and Manufacturing Organization) focused on providing high-purity mRNA and LNP-mRNA solutions. Their mission is to support mRNA therapeutic and vaccine programs with scalable, high-quality manufacturing, process development, and analytical services, ensuring precision, speed, and compliance from research to clinical trials.

Products & Services

Catalog mRNA Products:High-quality mRNA products for research and clinical applications, available for immediate order.

Custom mRNA:Tailored mRNA synthesis services to meet specific research and development needs.

GMP mRNA and LNP-mRNA Manufacturing:Good Manufacturing Practice (GMP) compliant production of mRNA and lipid nanoparticle (LNP) formulations for clinical use.

LNP-Formulated mRNA:mRNA encapsulated in lipid nanoparticles for enhanced delivery in therapeutic applications.

mRNA and LNP Analytical Services:Comprehensive analytical testing and quality control for mRNA and LNP products.

mRNA and LNP Large-Scale Production:Scalable manufacturing solutions for large-scale production of mRNA and LNP formulations.

mRNA Sequence Design:Custom design of mRNA sequences to optimize therapeutic or research outcomes.

Pre-GMP mRNA and LNP Development:Development services for mRNA and LNP products prior to GMP manufacturing, focusing on preclinical stages.

Specialties

mRNA Manufacturing LNP Formulation Process Development Analytical Services GMP Manufacturing Scalable Production

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Funding Round T: - FT: Funding Round	A: 20000000 MR: - FA: 20MM FAN: 20000000	D: 2023-06-27 FD: 2023-06-27	4 investors

Funding Round Latest

2023-06-27

$20.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Christian Cobaugh

Chief Scientific Officer and Founder

R

Robert Myers

Senior Vice President, Operations

G

Grant Henderson

Senior Director, Commercial and Technical Operations

D

David Q. Anderson

Board Member, General Partner at Ampersand Capital Partners

D

Daniella Kranjac

Board Member

E

Errik B. Anderson

Board Member, CEO and Founder of Alloy Therapeutics

View 5 more team members with Pro

Unlock Full Team Directory

Recent News